![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | |
A61P 35/00 | |||
C07K 16/18 | |||
A61K 31/282 | |||
A61K 31/519 | |||
C07K 16/28 |
(11) | Number of the document | 3212233 |
(13) | Kind of document | T |
(96) | European patent application number | 15856100.1 |
Date of filing the European patent application | 2015-10-30 | |
(97) | Date of publication of the European application | 2017-09-06 |
(45) | Date of publication and mention of the grant of the patent | 2020-06-24 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/058327 |
Date | 2015-10-30 |
(87) | Number | WO 2016/070051 |
Date | 2016-05-06 |
(30) | Number | Date | Country code |
201462073634 P | 2014-10-31 | US | |
201562127172 P | 2015-03-02 | US | |
201562192133 P | 2015-07-14 | US | |
201562242567 P | 2015-10-16 | US |
(72) |
MURRIEL, Christopher Lamond, US
HOEY, Timothy Charles, US
GURNEY, Austin L., US
RODA, Julie Michelle, US
SRIVASTAVA, Minu K., US
PARK, Inkyung, US
DUPONT, Jakob, US
|
(73) |
Oncomed Pharmaceuticals, Inc.,
800 Chesapeake Drive, Redwood City, CA 94063-4748,
US
|
(54) | COMBINATION THERAPY FOR TREATMENT OF DISEASE |
COMBINATION THERAPY FOR TREATMENT OF DISEASE |